1-241500572-A-G

Variant summary

Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong

The NM_000143.4(FH):​c.1255T>C​(p.Ser419Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000188 in 1,598,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S419A) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0000069 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

FH
NM_000143.4 missense

Scores

15
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: 7.00

Publications

2 publications found
Variant links:
Genes affected
FH (HGNC:3700): (fumarate hydratase) The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]
FH Gene-Disease associations (from GenCC):
  • hereditary leiomyomatosis and renal cell cancer
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • fumaric aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pheochromocytoma-paraganglioma
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • leiomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 17 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 37 uncertain in NM_000143.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-241500572-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2805452.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 132 curated pathogenic missense variants (we use a threshold of 10). The gene has 17 curated benign missense variants. Gene score misZ: 1.2708 (below the threshold of 3.09). Trascript score misZ: 2.0634 (below the threshold of 3.09). GenCC associations: The gene is linked to fumaric aciduria, hereditary leiomyomatosis and renal cell cancer, hereditary pheochromocytoma-paraganglioma, leiomyosarcoma, pheochromocytoma-paraganglioma.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.909
PP5
Variant 1-241500572-A-G is Pathogenic according to our data. Variant chr1-241500572-A-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 92451.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000143.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FH
NM_000143.4
MANE Select
c.1255T>Cp.Ser419Pro
missense
Exon 9 of 10NP_000134.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FH
ENST00000366560.4
TSL:1 MANE Select
c.1255T>Cp.Ser419Pro
missense
Exon 9 of 10ENSP00000355518.4
FH
ENST00000683521.1
c.1255T>Cp.Ser419Pro
missense
Exon 9 of 9ENSP00000506864.1
FH
ENST00000493477.2
TSL:3
n.1758T>C
non_coding_transcript_exon
Exon 9 of 10

Frequencies

GnomAD3 genomes
AF:
0.00000685
AC:
1
AN:
145970
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000254
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1452482
Hom.:
0
Cov.:
32
AF XY:
0.00000277
AC XY:
2
AN XY:
722786
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33324
American (AMR)
AF:
0.00
AC:
0
AN:
44546
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25840
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39434
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86150
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5570
European-Non Finnish (NFE)
AF:
9.05e-7
AC:
1
AN:
1105130
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000685
AC:
1
AN:
145970
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
70652
show subpopulations
African (AFR)
AF:
0.0000254
AC:
1
AN:
39394
American (AMR)
AF:
0.00
AC:
0
AN:
14356
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3440
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4918
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4560
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66786
Other (OTH)
AF:
0.00
AC:
0
AN:
1988
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Sep 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 419 of the FH protein (p.Ser419Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hereditary leiomyomatosis and renal cell cancer (HLRCC) (PMID: 15937070; internal data). It has also been observed to segregate with disease in related individuals. This variant is also known as c.1126T>C (p.Ser376Pro). ClinVar contains an entry for this variant (Variation ID: 92451). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt FH protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects FH function (PMID: 16597677). For these reasons, this variant has been classified as Pathogenic.

Dec 20, 2012
Eurofins Ntd Llc (ga)
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 04, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PP3, PP4, PM2_moderate, PS4_moderate

Jan 27, 2020
Revvity Omics, Revvity
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary leiomyomatosis and renal cell cancer Pathogenic:2
Jul 06, 2023
Myriad Genetics, Inc.
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 15937070, 31831373, 26945337]. Functional studies indicate this variant impacts protein function [PMID: 16597677]. This variant is expected to disrupt protein structure [Myriad internal data].

Jan 17, 2017
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary cancer-predisposing syndrome Pathogenic:2
May 04, 2023
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.S419P mutation (also known as c.1255T>C), located in coding exon 9 of the FH gene, results from a T to C substitution at nucleotide position 1255. The serine at codon 419 is replaced by proline, an amino acid with some similar properties. This alteration, also designated as S376P (1126T>C) in the literature, has been observed several individuals with a personal and/or family history that is consistent with HLRCC-related disease (Wei MH et al. J. Med. Genet. 2006 Jan;43(1):18-27; Sanz-Ortega J et al. Am J Surg Pathol. 2013 Jan;37:74-80; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

Jun 18, 2021
Sema4, Sema4
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

Fumarase deficiency;C1708350:Hereditary leiomyomatosis and renal cell cancer Pathogenic:1
Apr 17, 2024
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FH-related disorder Pathogenic:1
Jan 12, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The FH c.1255T>C variant is predicted to result in the amino acid substitution p.Ser419Pro. This variant is alternately referred to as p.Ser376Pro using Legacy nomenclature. This variant has been reported in individuals and families with hereditary leiomyomatosis and renal cell cancer (HLRCC; Table 1, Figure 3, Family 4400, Wei et al. 2006. PubMed ID: 15937070; Pithukpakorn et al. 2006. PubMed ID: 16597677; Lehtonen et al. 2011. PubMed ID: 21404119; Table 1, Sanz-Ortega et al. 2013. PubMed ID: 23211287; Table S1, Scharnitz et al. 2023. PubMed ID: 36777509). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic and pathogenic in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/92451/). This variant is interpreted as pathogenic for autosomal dominant and recessive FH-associated disorders.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.57
D
BayesDel_noAF
Pathogenic
0.58
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.93
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.54
D
MetaRNN
Pathogenic
0.91
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.9
H
PhyloP100
7.0
PrimateAI
Uncertain
0.74
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Pathogenic
0.82
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.94
MutPred
0.47
Loss of MoRF binding (P = 0.0866)
MVP
0.99
MPC
1.1
ClinPred
1.0
D
GERP RS
5.7
Varity_R
0.94
gMVP
0.99
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200004220; hg19: chr1-241663872; API